Recently MCR American Pharmaceuticals debuted a new cold fighting remedy called Congestinex C that aims to relieve flu like symptoms.
Brooksville, Florida — May 7, 2012
The newest MCR American Pharmaceuticals product called Congestinex C was released two weeks ago and is marketed directly to medical professionals and the general public.
Congestinex C is an antihistamine, available in grape flavor and is recommended for patients who have post-nasal drip cough. Congestinex C can help calm a runny nose and may stop sneezing.
For the most part, FDA experts do not recommend young children consume cold-fighting over-the-counter medications, yet Congestinex C is safe for those older than age two. MCR American Pharmaceuticals designed Congestinex C to suit young children by using lower doses of Chlorpheniramine, and Dextromethorphan.
“We created Congestinex C to relieve cold and flu-like symptoms for even the youngest of our patients,” said Danny Ambrose, an executive at MCR American Pharmaceuticals.
Since MCR American Pharmaceuticals sells its medications directly to medical professionals and consumers, patients receive the medications at a reduced price. Rather than work with a middleman, MCR American Pharmaceuticals works directly with its customers, thus the company removes the unnecessary costs of paying a distributor and is able to sell its own products at a more affordable price.
“This is a win-win situation for everyone,” said Ambrose. “Doctors receive their medications faster and patients receive cheaper medications.”
MCR American Pharmaceuticals manufactures other cold-fighting product families: Maxiphen, Maxifed and Super-Tuss. Each medication group consists of products that are sold on the company’s Web site and aim to relieve patients from colds and flu-like symptoms.
“MCR American Pharmaceuticals is dedicated to providing individuals with self medication products for in-home treatment and prevention of medical conditions and ailments,” Ambrose said. “We continuously strive to manufacture products that really make a difference.”
Brooksville-based specialty pharmaceutical company MCR American Pharmaceuticals is focused on the marketing and development of the highest quality pharmaceuticals. MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, AL. and quickly expanded to several states in the Southeast. In 1999, MCR American Pharmaceuticals was purchased by Dave Ambrose and was relocated to Brooksville, FL. and in 2008 the company was acquired by Neuro-HiTech. Today MCR American Pharmaceuticals’ products are marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and local pharmacies.
For additional information, interview and image requests contact Virtuos Online.